$VCEL

Halpin Michael sold $402K of VCEL

Halpin Michael (Chief Operating Officer) sold 10,000 shares of Vericel Corp (VCEL) at $40.24 ($0.40M total) on 2026-06-18 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Halpin Michael
Published Jun 22, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 22, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VCEL
Neutral
medium confidence
Mentioned
$VCEL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VCELNeutralLow
01

Why it matters

The only new information is the disclosed sale size, price, and that it was executed under a pre-arranged 10b5-1 plan; no new company fundamentals are provided.

02

Market read

Traders may note insider selling, but the 10b5-1 framing reduces the likelihood of a strong negative signal.

03

What to watch

The filing does not state motivations, and the post-transaction holdings (16,248 shares) suggest the insider did not exit the position.

Relevance 3/10Novelty 5/10Timing: new Form 4 filed 2026-06-22 (sale executed 2026-06-18)

Background

This is an SEC Form 4 insider transaction disclosure for Vericel Corp (VCEL) by COO Michael Halpin.

Company-level read

Ticker impact

$VCELNeutralMedium confidence
Context

Vericel COO Michael Halpin sold 10,000 shares in an open-market transaction at $40.2400 on 2026-06-18 under a 10b5-1 plan.

Expected impact

Minimal near-term impact; any effect is likely short-lived unless accompanied by unusual follow-on selling or other company-specific news.

Evidence & confidence

The filing is a standard insider sale with a pre-arranged 10b5-1 plan and no accompanying fundamental catalyst in the text.

Market effects

No sector read-through; this is a single-company insider transaction with no operational or regulatory details.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Vericel Corp

    Company whose insider transaction is disclosed (VCEL).

  • Michael Halpin

    Chief Operating Officer reporting the sale.

  • 10b5-1 plan

    Pre-arranged plan indicating the sale was scheduled in advance.

Related articles

$VCELMedAI 8/10

Vericel Q2 Earnings Call Highlights

Vericel (NASDAQ: VCEL) reported Q2 earnings call updates. Burn Care revenue rose 22% to about $12M, with Epicel at $10.4M and NexoBrid above $1.5M. 2026 guidance was raised to $330M-$340M total revenue, MACI to $284M-$290M, Burn Care to $46M-$50M, and Q3 revenue to $76.5M-$78.5M. Board authorized a $200M buyback.

$VCELHigh

Vericel Corp (VCEL): Results of Operations and Financial Condition

Vericel Corp (VCEL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningsreleaseq22026.htm EX-99.1 Document Exhibit 99.1 Vericel Corporation 25 Blue Sky Drive Burlington, MA 01803 T 617 588-5555 F 617 588-5554 www.vcel.com Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Sh